Chemokines and Chemokine Receptors in the Development of NAFLD
Authors:
- 29 June 2018
- book chapter
- Published by Springer Nature
- Vol. 1061, 45-53
Abstract
Chemokines are chemo-attractants for leukocyte trafficking, growth, and activation in injured and inflammatory tissues. The chemokine system is comprised of 50 chemokine ligands and 20 cognate chemokine receptors. In the context of liver diseases, leukocytes, hepatocytes, hepatic stellate cells, endothelial cells, and vascular smooth muscle cells are capable of producing chemokines. Chemokine receptors are typically expressed in various leukocyte subsets. Given that inflammation is a critical factor for the transition from simple steatosis to non-alcoholic steatohepatitis (NASH), and fibrosis, the chemokine system may play a prominent role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Indeed, accumulating evidence shows elevated expression of chemokines and their receptors in the livers of obese patients with advanced steatosis and NASH. This chapter will discuss the underlying molecular mechanisms and the therapeutic potential of the chemokine systems in the pathogenesis of NAFLD. Among chemokines, we will highlight CCL2, CCL5, CXCL8-10, CX3CL1, and CXCL16 as pivotal mediators in the development of steatosis, NASH, and fibrosis.Keywords
This publication has 59 references indexed in Scilit:
- Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitisClinical Science, 2012
- Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2American Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceJournal of Clinical Investigation, 2010
- CX3CL1-CX3CR1 Interaction Prevents Carbon Tetrachloride-Induced Liver Inflammation and Fibrosis in MiceHepatology, 2010
- The Role of Chemokines in the Recruitment of Lymphocytes to the LiverDigestive Diseases, 2010
- Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and HumansGastroenterology, 2009
- CCR2 promotes hepatic fibrosis in mice #Hepatology, 2009
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityJournal of Clinical Investigation, 2006